Navigation Links
Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
Date:3/10/2009

CARMEL, Ind., March 10 /PRNewswire/ -- Christine Lawless, MD, has accepted the position as Medical Director of CME Enterprise, an ACCME-accredited provider of continuing medical education (CME), beginning March 2, 2009. Recognized as one of the world's leading authorities in sports medicine cardiology, Dr. Lawless recently completed her clinical tenure at The Ohio State University Medical Center, where she was Associate Professor of Internal Medicine and Co-Director of Ross Heart Hospital Lipid Clinic.

"Placing Dr. Lawless as Medical Director greatly increases opportunities to engage in cardiovascular and sports medicine, ensuring that the CME Enterprise team will continue its growth as a consummate professional education resource for quality CME," said CME Enterprise owner Deborah Wood.

"I look forward to working with my new colleagues at CME Enterprise as we continue to develop the most relevant curriculum for healthcare professionals," said Dr. Lawless. "The areas of greatest interest and expertise that I bring to CME Enterprise include preventive cardiology, lipids, hypertension, cardiomyopathy, heart disease in athletes, sports cardiology, sudden cardiac arrest and sports medicine."

Dr. Lawless is board certified in internal medicine, cardiovascular disease clinical lipidology¸ and sports medicine. She also is Chair of the US Figure Skating Sports Sciences and Sports Medicine Committee and also Head Team Physician for US Figure Skating. Dr. Lawless serves on the Advisory Board for the National Sudden Cardiac Arrest Association. She holds many other appointments in academic medicine and hospital-based clinical care. "With her expertise and extensive experience in academic and clinical medicine, Dr. Lawless will enable CME Enterprise to establish educational excellence not only in cardiovascular science, but also internal sports medicine for athletes," said CME Enterprise President Bruce J. Bellande, PhD, FACME, CCMEP.

About CME Enterprise

CME Enterprise, an innovative education company, is an ACCME-accredited provider with Exemplary Status in Mission, Needs Assessment, and Effective Measurement of Activities. CME Enterprise develops extensive needs assessments, executes needs-based and competency-based curricula, and impacts physician knowledge and patient outcomes through local, national, and international CME interventions. By engaging in continuous clinical practice performance improvement and healthcare systems quality improvement, CME Enterprise has set itself apart from other medical education companies. For more information about CME Enterprise, visit its Web site at www.cmeenterprise.com.

    Media contact:
    McKenna Goslee
    (317) 846-2879


'/>"/>
SOURCE CME Enterprise
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... in attendance control systems is proud to announce the introduction of fingerprint attendance control ... right employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - ...
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):